p.Ile512Leu TNNI3k変異と関連した拡張心筋病の最初の表れとして,十代の患者における時計回りのバンドルブランチ再侵入性心房不全症:症例報告
Marta González-Quijano1, Juan Acosta1, Manuel Frutos-López1
1Cardiology Department, Arrhythmia Section, Virgen del Rocío University Hospital, Avda Manuel Siurot s/n, Seville 41013, Spain.
European heart journal. Case reports
|September 4, 2025
まとめ
TNNI3Kの希少な遺伝子変異により,十代の若者において,バンドル・ブランチ・リエントラント・ヴァントリキュラー・タヒカルディア (BBRVT) とファミリアル・ディラテッド・カーディオミオパシーが発生した. 遺伝子検査は 原因不明の心臓のリズムや 伝導に問題がある若い患者にとって 極めて重要です
科学分野:
- 心臓病科
- 遺伝学
- 電気生理学
背景:
- バンドル・ブランク・リエントラント・ヴァントリキュラー・タヒカルディア (BBRVT) は,心臓病を患っている患者にしばしば影響します.
- 遺伝的要因は,特に心臓の構造的異常のない若い個人に BBRVT を引き起こす可能性があります.
- 伝導障害はBBRVTの病理生理学において重要なものです.
研究 の 目的:
- 若い患者のBBRVTの 新症例を報告する
- BBRVTと関連する心筋病の遺伝的基礎を調査する.
- 未解明の心房不律症における 遺伝子検査の臨床的重要性を強調するためです
主な方法:
- BBRVTを診断するための電気生理学的試験
- 原因となる変異を特定するための遺伝分析
- 構造評価のための心臓磁気共鳴画像 (CMR)
- 家族の共同分離分析
主要な成果:
- 17歳の男性で 時計時計の方向でBBRVTと 導電性異常を呈した
- 新しいTNNI3K遺伝子変異 (p.Ile512Leu) が特定されました.
- 漸進的な左心室機能障害と拡張が観察され,家族性拡張性心筋病と一致しました.
- TNNI3K変異体と心異常との関連が確認されました.
結論:
- このケースでは,BBRVTが若い患者のTNNI3K関連家族性拡張性心筋病の初期症状であることを示しています.
- 静脈動脈不全や伝導障害を患っている若者の診断と治療には 遺伝子検査が不可欠です
- TNNI3K遺伝子は,リズムと構造の両方に影響を及ぼす遺伝性心疾患に関与しています.
関連する概念動画
Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
Cardiomyopathy III: Hypertrophic Cardiomyopathy
45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
Cardiomyopathy I: Introduction and Classification
49
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
49
Cardiomyopathy IV: Restrictive Cardiomyopathy
25
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
25
Mitral Valve Prolapse I: Introduction
38
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
38
Mitral Stenosis II: Clinical features and Diagnostic Tests
36
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
36


